Company news

Axsome Therapeutics, Inc. news in 2021

Axsome Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update

November 7, 2021

Axsome Therapeutics to Report Third Quarter 2021 Financial Results on November 8, 2021

October 19, 2021

Axsome Therapeutics Expands Term Loan Facility with Hercules Capital to $300 Million

October 17, 2021

Axsome Therapeutics Initiates SYMPHONY Phase 3 Trial of AXS-12 in Narcolepsy

September 15, 2021

Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-07 for the Acute Treatment of Migraine

September 13, 2021

Axsome Therapeutics Provides Update on the New Drug Application for AXS-05 for the Treatment of Major Depressive Disorder

August 22, 2021

Axsome Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update

August 8, 2021

Axsome Therapeutics Announces AXS-05 Achieves Primary and Key Secondary Endpoints in the MERIT Phase 2 Trial in Treatment Resistant Depression

August 8, 2021

Axsome Therapeutics to Report Second Quarter 2021 Financial Results on August 9, 2021

July 14, 2021

Axsome Therapeutics Announces Planned NDA Submission for AXS-14 for the Management of Fibromyalgia

June 14, 2021

Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update

May 9, 2021

Axsome Therapeutics Joins Mental Health America and other Advocacy Organizations in Raising Awareness and Providing Support for Mental Health During Mental Health Month

May 6, 2021

Axsome Therapeutics to Report First Quarter 2021 Financial Results on May 10, 2021

April 26, 2021

Axsome Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for AXS-05 for Treatment of Major Depressive Disorder

April 25, 2021

Axsome Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

February 28, 2021

Axsome Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021

February 15, 2021

Calls in 2021

Decks in 2021